MSKCC Center for Molecular Oncology (CMO)

@MskccCMO

The Marie-Josée and Henry R. Kravis Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center, NYC

Vrijeme pridruživanja: listopad 2019.
3 fotografije ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @MskccCMO

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MskccCMO

  1. proslijedio/la je Tweet
    29. sij

    📣 Spread the word about your ride! 📣 Repost these pics to help raise money and recruit for your team. Head to our resources page to download more images and GIFs!

    4 proslijeđena tweeta 4 korisnika označavaju da im se sviđa
    Poništi
  2. proslijedio/la je Tweet
    29. sij

    ⁦⁩ delivering his annual tour de force “State of the ⁦⁦⁩” - galvanizing his people!

    2 proslijeđena tweeta 29 korisnika označava da im se sviđa
    Poništi
  3. proslijedio/la je Tweet
    29. sij

    Excited for Feb 5 all star ⭐️ ⭐️⭐️⭐️⭐️⭐️ line up. Please register and participate in the expert discussion. free registration & food

    10 proslijeđenih tweetova 36 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  4. 28. sij

    Check out the first of our Tuesday Twinterviews, featuring CMO members Debyani Chakravarty and Brian Houck-Loomis!

    i
    8 proslijeđenih tweetova 31 korisnik označava da mu se sviđa
    Poništi
  5. proslijedio/la je Tweet
    24. sij

    lotsa❤️ to these kids:Trekking after school to from Brooklyn Latin every Wed to learn abt Cancer Biology(w/ instructors like me, & pic'd here Dr. Jose Reyes) via SEP HOPP by & Emily Delgado

    1 reply 3 proslijeđena tweeta 46 korisnika označava da im se sviđa
    Poništi
  6. proslijedio/la je Tweet
    22. sij

    Neat study. ⁦⁩’s ⁦⁩ weighs in here:

    5 proslijeđenih tweetova 2 korisnika označavaju da im se sviđa
    Poništi
  7. proslijedio/la je Tweet
    22. sij

    Excited to share our finding that many rare and even private mutations in spliceosomal genes are likely pathogenic! Great collaboration with and others, just out in .

    36 proslijeđenih tweetova 98 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  8. proslijedio/la je Tweet
    7. sij

    Another 2020 milestone: MSK-IMPACT has sequenced >50K patient samples. Excellent tweetorial from 👇about the implications of NGS as a part of routine care for patients with advanced cancer

    The prospective clinical MSKCC NGS cohort is now >50,000 samples sequenced. Thanks to the hundreds of physicians, laboratory technicians, data scientists, nurses and support staff who have made this initiative possible. A few thoughts on what we have learned.
    Prikaži ovu nit
    9 proslijeđenih tweetova 55 korisnika označava da im se sviđa
    Poništi
  9. proslijedio/la je Tweet
    13. sij

    “We now understand metastasis as the regeneration of the wrong tissue — the tumor — in the wrong place — distant vital organs,” Joan Massagué,

    15 replies 420 proslijeđenih tweetova 702 korisnika označavaju da im se sviđa
    Poništi
  10. proslijedio/la je Tweet
    14. sij

    If you haven't already, NOW is your chance to register! is 90% full for the 2020 rides. Don't miss out! Click here to start a team or join a team before the bikes are completely full:

    5 proslijeđenih tweetova 11 korisnika označava da im se sviđa
    Poništi
  11. proslijedio/la je Tweet
    6. sij

    After ~11 years, last week was officially my last at - very emotional. I leave MSK more in awe of its people (MDs, PhDs, RNs, techs, aids, +others), culture, and mission then when I first arrived. MSK is why I became oncologist & later a cancer researcher. 1/4

    14 replies 14 proslijeđenih tweetova 267 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  12. proslijedio/la je Tweet
    9. sij

    The American Cancer Society estimates that 2.9 million cancer deaths have been averted since 1991 because of a decline in smoking prevalence and improvement in the early detection and treatment of cancer.

    1 reply 19 proslijeđenih tweetova 54 korisnika označavaju da im se sviđa
    Poništi
  13. proslijedio/la je Tweet
    9. sij

    No wonder is so hard to crack😉 and these are just the splicing alterations

    11 replies 167 proslijeđenih tweetova 462 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  14. proslijedio/la je Tweet
    7. sij

    The prospective clinical MSKCC NGS cohort is now >50,000 samples sequenced. Thanks to the hundreds of physicians, laboratory technicians, data scientists, nurses and support staff who have made this initiative possible. A few thoughts on what we have learned.

    14 replies 169 proslijeđenih tweetova 467 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  15. proslijedio/la je Tweet
    27. pro 2019.

    Year in Review: 10 Important Clinical Research Discoveries in 2019 | Memorial Sloan Kettering Cancer Center

    7 proslijeđenih tweetova 16 korisnika označava da im se sviđa
    Poništi
  16. proslijedio/la je Tweet
    24. pro 2019.

    One important finding - TRK fusion-positive cancers are depleted of other mitogenic drivers. congrats on pulling together this paper that covers genomics, natural history, and prevalence!

    25 proslijeđenih tweetova 84 korisnika označavaju da im se sviđa
    Poništi
  17. proslijedio/la je Tweet
    22. pro 2019.

    Meet the scientists who will be using the advanced super microscope that you’re funding! They wanted to say THANK YOU for helping raise $1 million for the microscope that will elevate the way they are studying the cause of cancer.

    1 reply 7 proslijeđenih tweetova 39 korisnika označava da im se sviđa
    Poništi
  18. proslijedio/la je Tweet
    17. pro 2019.

    we will miss you!!

    1 proslijeđeni tweet 15 korisnika označava da im se sviđa
    Poništi
  19. proslijedio/la je Tweet
    16. pro 2019.

    👀 Great leadership opportunity to work closely with our team (49,000 tumors sequenced to date)

    Memorial Sloan Kettering is seeking a Chief of the Early Drug Development and Immunotherapy Service, whose mission is to lead the translation of novel cancer therapeutics from the lab to the clinic. Applicants should send a CV and brief statement to eddchiefsearch@mskcc.org.
    Prikaži ovu nit
    8 proslijeđenih tweetova 21 korisnik označava da mu se sviđa
    Poništi
  20. proslijedio/la je Tweet
    16. pro 2019.

    See below - amazing opportunity at a top notch center with fantastic people and state of the art resources!

    Memorial Sloan Kettering is seeking a Chief of the Early Drug Development and Immunotherapy Service, whose mission is to lead the translation of novel cancer therapeutics from the lab to the clinic. Applicants should send a CV and brief statement to eddchiefsearch@mskcc.org.
    Prikaži ovu nit
    1 proslijeđeni tweet 7 korisnika označava da im se sviđa
    Poništi

@MskccCMO još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·